CAS RN 366789-02-8
Rivaroxaban, 98 %
CAS: 366789-02-8 Molekylformel: C19H18ClN3O5S Molekylvikt (g/mol): 435.88 MDL-nummer: MFCD11974010 InChI-nyckel: KGFYHTZWPPHNLQ-UHFFFAOYNA-N Synonym: rivaroxaban,xarelto,s-5-chloro-n-2-oxo-3-4-3-oxomorpholino phenyl oxazolidin-5-yl methyl thiophene-2-carboxamide,unii-9ndf7jz4m3,xarelto tn,9ndf7jz4m3,5-chloro-n-5s-2-oxo-3-4-3-oxomorpholin-4-yl phenyl-1,3-oxazolidin-5-yl methyl thiophene-2-carboxamide,2-thiophenecarboxamide, 5-chloro-n-5s-2-oxo-3-4-3-oxo-4-morpholinyl phenyl-5-oxazolidinyl methyl,5-chloro-n-5s-2-oxo-3-4-3-oxo-4-morpholinyl phenyl-5-oxazolidinyl methyl-2-thiophenecarboxamide PubChem CID: 9875401 ChEBI: CHEBI:68579 IUPAC-namn: 5-klor-N-[[(5S)-2-oxo-3-[4-(3-oxomorfolin-4-yl)fenyl]-1,3-oxazolidin-5-yl]metyl]tiofen-2-karboxamid LEDER: ClC1=CC=C(S1)C(=O)NCC1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O
Rivaroxaban, TRC
CAS: 366789-02-8 Molekylformel: C19 H18 Cl N3 O5 S Molekylvikt (g/mol): 435.88 Synonym: 2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-,5-Chloro-N-([(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl]-methyl)-2-thiophenecarboxamide,5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl]methyl]-2-thiophenecarboxamide,5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide,5-Chloro-N-[[(S)-3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]-thiophene-2-carboxamide,BAY 59-7939,Rivaroxaban,Xarelto IUPAC-namn: 5-kloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorfolin-4-yl)fenyl]-1,3-oxazolidin-5-yl]metyl]tiofen-2-karboxamid LEDER: Clc1ccc(s1)C(=O)NC[C@H]2CN(C(=O)O2)c3ccc(cc3)N4CCOCC4=O
Rivaroxaban, Mikromol™
Discover Mikromol – din pålitliga källa för högkvalitativa läkemedelsreferensstandarder. Stöder noggrann, regelrätt analys med material som är ackrediterat 17034 ISO och utformat för att säkerställa förtroende för varje resultat.
Rivaroxaban, MedChemExpress
MedChemExpress Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM).